Bethesda, MDNCT04545736Now EnrollingIRB Ready

Stargardt Disease Clinical Trial in Bethesda, MD

Access cutting-edge stargardt disease treatment through this clinical trial at a research site in Bethesda. Study-provided care at no cost to qualified participants.

Sponsored by National Eye Institute (NEI)

Quick Self-Assessment

See if you qualify for this Bethesda location

Preparing your pre-screening questions...

Expert Care in Bethesda

Access stargardt disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related stargardt disease treatment provided free

Apply for This Bethesda Location

Check if you qualify for this stargardt disease clinical trial in Bethesda, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Bethesda

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Bethesda site if eligible
  4. 4Begin participation

About This Stargardt Disease Study in Bethesda

Background: ABCA4 retinopathy is a genetic disease in which the ABCA4 protein is absent or faulty. It can cause waste material to collect in the eye and may cause cells to die. The cell death can lead to vision loss. Researchers want to see if an oral drug called metformin can help. Objective: To see if metformin is safe and possibly helps to slow the rate of ABCA4 retinopathy. Eligibility: People age 12 and older who have ABCA4 retinopathy and have problems with their vision. Design: Par

Sponsor: National Eye Institute (NEI)

Who Can Participate

Inclusion Criteria

To be eligible, the following inclusion criteria must be met, where applicable. 1. Participant must be at least 12 years of age. 2. Participant (or legal guardian) must understand and sign the protocol s informed consent document. 3. Participant must have at least one definite pathogenic or likely pathogenic mutation in ABCA4 and a typical clinical presentation of Stargardt disease and phenotypic presentation of ABCA4 retinopathy in both eyes. 4. Participant must have at least two years of natural history data from at least four data points (a) The separation between any two consecutive data points must be at least six months (b) The most recent data point must be at least 4.5 months and no more than 16 months prior to the baseline visit (c) 1. Potential participants with three natural history data points may be enrolled to obtain their fourth natural history data point on protocol. 2. The separation between any two consecutive data points may fall short

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Bethesda?

Yes, this clinical trial (NCT04545736) has an active research site in Bethesda, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Stargardt Disease Treatment Options in Bethesda, MD

If you're searching for stargardt disease treatment options in Bethesda, MD, this clinical trial (NCT04545736) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Bethesda research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stargardt disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all stargardt disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Bethesda, MD

See all ankylosing spondylitis clinical trials recruiting in Bethesda — not just this study.

Browse Ankylosing Spondylitis Trials in Bethesda →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsGeographic Atrophy TrialsAll Conditions →

Ready to Join in Bethesda?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Bethesda, MD